World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
78
Citations
23699
World Ranking
1073
National Ranking
559

David M. Kranz publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where David M. Kranz sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 284 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

David M. Kranz D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where David M. Kranz sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 78 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2019 - Fellow, National Academy of Inventors

Overview

David M. Kranz is affiliated with the University of Illinois at Urbana-Champaign in the United States. Their research primarily spans the field of Medicine with a focus on oncology, infectious diseases, immunology, molecular biology, and radiology, nuclear medicine, and imaging.

The scientist's work is concentrated on several main topics, including:

  • CAR-T cell therapy research
  • SARS-CoV-2 and COVID-19 research
  • SARS-CoV-2 detection and testing
  • Monoclonal and polyclonal antibodies research
  • Immunotherapy and immune responses
  • COVID-19 epidemiological studies
  • Immune cell function and interaction

Frequent co-authors collaborating with David M. Kranz include:

  • Preeti Sharma
  • Diana Rose E. Rañoa
  • Venkata V.V.R. Marada
  • Steven P. Wolf
  • Karin Schreiber

Common publication venues for their research work are:

  • Journal for ImmunoTherapy of Cancer
  • Cancer Research
  • Science
  • Neuro-Oncology
  • Proceedings of the National Academy of Sciences

Notable recent papers by David M. Kranz include:

  • "Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2," 2020, Science
  • "Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine," 2020, Neuro-Oncology
  • "Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides," 2020, Proceedings of the National Academy of Sciences
  • "Mitigation of SARS-CoV-2 transmission at a large public university," 2022, Nature Communications
  • "TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastoma," 2023, Journal for ImmunoTherapy of Cancer

David M. Kranz was awarded the title of Fellow of the National Academy of Inventors in 2019.

Best Publications

  • Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells

    Mercedes B. Fuertes;Aalok K. Kacha;Justin Kline;Seng Ryong Woo

  • Positive and negative selection of an antigen receptor on T cells in transgenic mice

    William C. Sha;Christopher A. Nelson;Rodney D. Newberry;David M. Kranz

  • Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences.

    Haruo Saito;David M. Kranz;Yohtaroh Takagaki;Adrian C. Hayday

  • APRIL: a processor architecture for multiprocessing

    Anant Agarwal;Beng-Hong Lim;David Kranz;John Kubiatowicz

  • A third rearranged and expressed gene in a clone of cytotoxic T lymphocytes.

    Haruo Saito;David M. Kranz;Yohtaroh Takagaki;Adrian C. Hayday

  • Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice.

    W C Sha;C A Nelson;R D Newberry;D M Kranz

  • Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.

    Avery D. Posey;Robert D. Schwab;Alina C. Boesteanu;Catharina Steentoft

  • Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.

    Kui K. Chan;Danielle Dorosky;Preeti Sharma;Shawn A. Abbasi

  • The MIT Alewife machine: architecture and performance

    Anant Agarwal;Ricardo Bianchini;David Chaiken;Kirk L. Johnson

  • Structure, organization, and somatic rearrangement of T cell gamma genes

    Adrian C. Hayday;Haruo Saito;Stephen D. Gillies;David M. Kranz

  • T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity.

    Jennifer D. Stone;Adam S. Chervin;David M. Kranz

  • Quantitative Analysis of the Contribution of TCR/pepMHC Affinity and CD8 to T Cell Activation

    Phillip D. Holler;David M. Kranz

  • Induced sensitization of tumor stroma leads to eradication of established cancer by T cells

    Bin Zhang;Natalie A. Bowerman;Joseph K. Salama;Hank Schmidt

  • THE MIT ALEWIFE MACHINE: A LARGE-SCALE DISTRIBUTED-MEMORY MULTIPROCESSOR

    A. Agarwal;D. Chaiken;K. Johnson;D. Kranz

  • In vitro evolution of a T cell receptor with high affinity for peptide/MHC

    Phillip D. Holler;Philmore O. Holman;Eric V. Shusta;Sean O'Herrin

  • Yeast cell surface display of proteins and uses thereof

    Dane K. Wittrup;Michele C. Kieke;David M. Kranz;Eric Shusta

  • Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli.

    Meegan Gruber;Beth A. Schodin;Erik R. Wilson;David M. Kranz;David M. Kranz

  • Directed evolution of a stable scaffold for T-cell receptor engineering

    E V Shusta;P D Holler;M C Kieke;D M Kranz

  • Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency.

    Eric V Shusta;Michele C Kieke;Evan Parke;David M Kranz

  • How a Single T Cell Receptor Recognizes Both Self and Foreign MHC

    Leremy A. Colf;Alexander J. Bankovich;Nicole A. Hanick;Natalie A. Bowerman

Frequent Co-Authors

Eric V. Shusta
Eric V. Shusta University of Wisconsin–Madison
Hans Schreiber
Hans Schreiber University of Chicago
Philip D. Greenberg
Philip D. Greenberg Fred Hutchinson Cancer Research Center
K. Christopher Garcia
K. Christopher Garcia Stanford University
Roy A. Mariuzza
Roy A. Mariuzza University of Maryland, College Park
Patrick M. Schlievert
Patrick M. Schlievert University of Iowa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying molecular biology opens doors to a wide array of career opportunities, both in research and applied fields. Many students discover that their interests and professional goals extend beyond the lab, intersecting with fields like healthcare, psychology, and counseling.

If you're interested in combining biology with social impact, consider a masters in social work online to prepare for roles in health advocacy or policy. For those drawn to the intersection of mental health and biology, you might explore a master psychologie à distance for a flexible pathway into psychological research or therapy.

Clinical counseling is another rewarding career. An online masters in clinical mental health counseling equips you with skills to support individuals facing mental health challenges, a valuable expertise in medical and community settings. Alternatively, those fascinated by the intersection of science and law may consider forensic psychology masters programs to pursue roles in criminal justice, legal consulting, or forensic research.

Each of these online degrees offers unique career pathways that complement a background in molecular biology, broadening your expertise and professional horizons.

Best Scientists Citing David M. Kranz

Trending Scientists

Recently Published Articles